Αποτελέσματα Αναζήτησης
25 Νοε 2019 · FRANKFURT/LONDON (Reuters) - European private equity firm CapVest has tapped potential bidders for its French nuclear medicine provider Curium, sources told Reuters, aiming for a deal that...
6 Απρ 2017 · Speaking on behalf of CapVest, the owner of Curium, Kate Briant, CapVest Partner and Chairman of the Board said, “We are excited to launch this dynamic new brand in the marketplace. We believe the expertise, size and scale, and proven track record of the united companies will provide future growth opportunities in this attractive segment.”
Curium is the world’s leading nuclear medicine company. Discover more about our background, our purpose and our values. What we do. How we work. Worldwide offices. With a global reach, Curium services customers in over 60 countries. See where we operate and find a local office. Management team.
We treat each other with respect, dignity and equality. We continue to forge partnerships that are built on trust and accountability. Curium's focus is to develop, manufacture and supply world-class nuclear medicine products to customers around the globe. Find out who we are.
Founders Renaud Dehareng. Operating Status Active. Legal Name Curium Holding France S.A.S. Company Type For Profit. Phone Number +33 1 69 85 76 76. Curium is a world-class nuclear medicine solutions provider with over 100 years of industry experience. Lists Featuring This Company. Ile-de-France Companies With More Than $100M in Revenue.
9 Ιαν 2020 · CVC Capital Partners, Bain Capital, Clayton Dubilier & Rice, Nordic Capital and PAI Partners have submitted first-round bids to acquire Curium Pharma from CapVest in a deal that would value the company at $3 billion or more, according to Bloomberg.
5 Απρ 2017 · Radiopharmacy vendor IBA Molecular has combined with recent acquisition Mallinckrodt Nuclear Medicine to form Curium, a new company with a mission to be a global developer, manufacturer, and supplier of SPECT, PET, and therapeutic radiopharmaceuticals.
